Seasonal analysis involves the study of how the price of an asset behaves at certain times of the year. The “Santa Claus ...

The AXS Knowledge Leaders ETF has a unique investment approach, focusing on innovative global companies with strong R&D and ...

Acadia is on track to achieve over $1 billion in annualized sales in 2025. The next phase of growth could come from two ...

The biotech industry has been described as the Wild West of the stock market. While that level of success is only obvious in ...

We recently published a list of 15 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at ...

As Oswego keeps booming, village officials are looking at the results of a new housing study that offers recommendations to ...

Wall Street is feeling optimistic about 2025, particularly against the backdrop of some of President-elect Donald Trump's pro ...

EST Cassava Sciences (SAVA) sinks 84% to $4.21 after Alzheimer’s study missDon't Miss our Black Friday Offers:Unlock your investing ...

From 2017 to Q3 2024, Nu grew its customer base from just 3 million to 110 million. For much of 2022 and 2023, the company was growing its revenues at over 100%. In 2024, growth has decelerated but is ...

Eli Lilly reported total tirzepatide sales that rocketed 272% year over year to $11 billion during the first nine months of ...

The company finished September with $1.9 billion in cash. A big cash pile gives CRISPR Therapeutics a long runway to ramp up ...